| 25/10/19 | 10:00:30 | 25 Oct 2019 | | Price Monitoring Extension | RNS |
| 20/09/19 | 15:05:53 | 20 Sept 2019 | | Second Price Monitoring Extn | RNS |
| 20/09/19 | 15:00:32 | 20 Sept 2019 | | Price Monitoring Extension | RNS |
| 10/09/19 | 17:49:46 | 10 Sept 2019 | | AGM Results | RNS |
| 10/09/19 | 08:00:23 | 10 Sept 2019 | | Directorate Change | RNS |
| 09/09/19 | 08:00:08 | 9 Sept 2019 | | Ebers Cannabinoid Collaboration Update | RNS |
| 06/09/19 | 08:30:04 | 6 Sept 2019 | | Appointment of Dr Muhunthan Thillai | RNS |
| 04/09/19 | 08:30:05 | 4 Sept 2019 | | Holding(s) in Company | RNS |
| 01/08/19 | 10:30:02 | 1 Aug 2019 | | Annual Financial Report | RNS |
| 29/07/19 | 08:00:09 | 29 Jul 2019 | | Holding(s) in Company | RNS |
| 18/07/19 | 08:00:06 | 18 Jul 2019 | | Final Results | RNS |
| 07/06/19 | 08:00:04 | 7 Jun 2019 | | Holding(s) in Company | RNS |
| 06/06/19 | 08:00:09 | 6 Jun 2019 | | Holding(s) in Company | RNS |
| 30/05/19 | 12:05:39 | 30 May 2019 | | Second Price Monitoring Extn | RNS |
| 30/05/19 | 12:00:37 | 30 May 2019 | | Price Monitoring Extension | RNS |
| 30/05/19 | 08:01:35 | 30 May 2019 | | Positive Results for NXP001 Clinical Trial | RNS |
| 28/05/19 | 08:00:06 | 28 May 2019 | | Holding(s) in Company - Amendment | RNS |
| 24/05/19 | 08:30:04 | 24 May 2019 | | Holding(s) in Company | RNS |
| 24/05/19 | 08:00:07 | 24 May 2019 | | Loan Conversion | RNS |
| 22/05/19 | 08:00:06 | 22 May 2019 | | Holding(s) in Company | RNS |
| 22/05/19 | 08:00:06 | 22 May 2019 | | Holding(s) in Company | RNS |
| 22/05/19 | 08:00:06 | 22 May 2019 | | Holding(s) in Company | RNS |
| 15/05/19 | 17:40:35 | 15 May 2019 | | Second Price Monitoring Extn | RNS |
| 15/05/19 | 17:35:45 | 15 May 2019 | | Price Monitoring Extension | RNS |
| 15/05/19 | 08:00:02 | 15 May 2019 | | Nuformix Achieves 2nd NXP001 Development Milestone | RNS |
| 10/05/19 | 10:00:38 | 10 May 2019 | | Price Monitoring Extension | RNS |
| 08/05/19 | 08:30:01 | 8 May 2019 | | Holding(s) in Company | RNS |
| 09/04/19 | 08:00:09 | 9 Apr 2019 | | Strategic Cannabinoid Agreement | RNS |
| 05/04/19 | 08:00:05 | 5 Apr 2019 | | Notification Major Share Interests | RNS |
| 22/03/19 | 07:00:03 | 22 Mar 2019 | | Nuformix Commences NXP001 Clinical Trial | RNS |
| 27/02/19 | 07:00:04 | 27 Feb 2019 | | MHRA approval for NXP001 | RNS |
| 20/02/19 | 18:16:44 | 20 Feb 2019 | | Holding(s) in Company | RNS |
| 20/12/18 | 07:00:05 | 20 Dec 2018 | | Unaudited Half Year Results | RNS |
| 03/12/18 | 07:00:07 | 3 Dec 2018 | | Reports Results from Novel IPF Pre-Clinical Trial | RNS |
| 27/11/18 | 07:00:04 | 27 Nov 2018 | | Expansion of NXP001 Agreement & Milestone Payment | RNS |
| 28/09/18 | 11:09:55 | 28 Sept 2018 | | Director/PDMR Shareholding | RNS |
| 28/09/18 | 08:00:10 | 28 Sept 2018 | | Additional New NXP002 Patent Filing | RNS |
| 19/09/18 | 15:33:10 | 19 Sept 2018 | | Result of AGM | RNS |
| 28/08/18 | 13:55:28 | 28 Aug 2018 | | Convertible Loan Amendment | RNS |
| 26/07/18 | 15:00:03 | 26 Jul 2018 | | Final Results | RNS |
| 09/07/18 | 10:33:17 | 9 Jul 2018 | | Holding(s) in Company | RNS |
| 02/07/18 | 08:00:04 | 2 Jul 2018 | | Operational Update | RNS |
| 11/05/18 | 08:00:04 | 11 May 2018 | | Dr Chris Blackwell Appointed NED | RNS |
| 24/04/18 | 12:54:00 | 24 Apr 2018 | | Holding(s) in Company | RNS |
| 11/04/18 | 17:41:10 | 11 Apr 2018 | | Stmnt re Share Price Movement | RNS |
| 02/03/18 | 13:30:01 | 2 Mar 2018 | | Update re: Broker | RNS |
| 27/02/18 | 09:37:10 | 27 Feb 2018 | | Holding(s) in Company | RNS |
| 31/01/18 | 07:00:05 | 31 Jan 2018 | | NXP002 Pilot Study in Lung and Liver Fibrosis | RNS |
| 15/12/17 | 07:30:01 | 15 Dec 2017 | | Agreement to License NXP001 | RNS |
| 14/12/17 | 07:00:05 | 14 Dec 2017 | | Dr Andy Richards Chairs Advisory Panel - New Appts | RNS |
